Universidade da Madeira
Funchal, Madeira, 9020-105, Portugal
NCT Number: NCT05038579
Dementia is a neurodegenerative syndrome that leads to cognitive deficits and, consequently, affects functionality and quality of life.
This study will explore the clinical impact of a customized cognitive stimulation program, using Musiquence.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Funchal, Madeira, 9020-105, Portugal
Dementia is a clinical syndrome characterized by a progressive and irreversible deterioration of cognitive functioning that impairs behavioral and functional domains. Within non-pharmacological approaches, Cognitive Stimulation Therapy (CST) is the most studied and well-established intervention for individuals with mild to moderate dementia. The underlying assumptions behind cognitive-based interventions of CST are:
Concerning the first assumption of cognitive-based interventions (a1), it is known that even in moderate to advanced stages of dementia, musical memory is one of the abilities that remain intact. It is hypothesized that music processing abilities precede the development of lexical language functions. This hypothesis is corroborated by findings that demonstrate that IwD are still responsive to music even when unable to communicate verbally or recognize words. Additionally, music is frequently associated with life experiences. Also, literature has reported that memories associated with specific music would be recollected longer than memories with no association to music; this suggests that using music as a reminiscence element on cognitive stimulation programs can have a promising effect on cognition. According to the second assumption of CST (a2), facilitating an enriching environment for IwD using, for , music and reminiscence elements could impact cognitive reserve and neuroplasticity.
In this context, Ferreira et al. developed a platform - Musiquence - that incorporates music and reminiscence in cognitive stimulation activities for IwD. Musiquence allows the gamification and personalization of 6 types of activities:
The platform is compatible with different technologies that allow adaptation to the patients' needs (motor difficulties, vision problems, tremble). Cognitive stimulation content can be personalized to the user since the caregivers can add text, images, and music when creating the tasks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The participants performed a customized cognitive stimulation program, that was implemented in an augmented reality format, using Musiquence.
Time frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
Change from baseline in the MMSE. Minimum of 0 points and maximum of 30 points. Higher scores mean better outcomes.
Time frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
Change from baseline in the ADAS-Cog. Minimum of 0 points and maximum of 68 points. Higher scores mean worse outcomes.
Time frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
Change from baseline in the QoL - AD. Minimum of 0 points and maximum of 52 points. Higher scores mean better outcomes.
Time frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
Change from baseline in the KLT. Minimum of 0 points and maximum of 100 ponints.Higher scores mean worse outcomes.
Time frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
Change from baseline in the SR Minimum of 0 points and maximum of 10 points.. Higher scores mean better outcomes.
Time frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
Change from baseline in the DSC. Minimum of 0 points and maximum of 10 points. Higher scores mean better outcomes.
Time frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
Change from baseline in the SPVF. Minimum of 0 points and no maximum. Higher scores mean better outcomes.
Time frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
Change from baseline in the IAFAI. Minimum of 0 points and maximum of 100 points. Higher scores mean worse outcomes.
Time frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
Change from baseline in the Cornell Scale for Depression in Dementia. Minimum of 0 points and maximum of 38 points. Higher scores mean worse outcomes.
Time frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
Change from baseline in the RAID. Minimum of 0 points and maximum of 54 points. Higher scores mean worse outcomes.
Universidade da Madeira
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07306065
Alzheimer Disease, Alzheimers Disease
Orlando, Florida, United States
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial Details